Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qingdao Vantolmin Biological Products is a Chinese biotechnology company specializing in the extraction and production of high-purity biological products from animal tissues. The company is a significant manufacturer of Urokinase, an enzyme used as a thrombolytic agent to treat various vascular disorders, and Chondroitin Sulfate, which is widely used in the treatment of osteoarthritis. Operating out of Qingdao, the firm focuses on large-scale production and export of these biochemical APIs (Active Pharmaceutical Ingredients) to international markets. Their business model centers on high-quality biochemical extraction and meeting global pharmacopeia standards for pharmaceutical and nutraceutical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qingdao Wan toulmin Biological Products.